2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Thursday, June 8, 2017

1:15pm-2:45pm: New method to evaluate new motor skill learning

A.P. Quixadá, V. Sotero, J.-F. Daneault, G. Diaz, Â. Torres, J.P. Vieira, M. Fonseca, P. Bonato, N. Peña, J.G. Miranda (Salvador, Brazil)

Other · Exhibit Hall C

1:15pm-2:45pm: Nilotinib differentially affects oligomeric α-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson’s disease with dementia and Lewy body dementia

F. Pagan, M. Hebron, Y. Torres-Yaghi, A. Lawler, T. Kimbason, N. Starr, B. Wilmarth, M. Arellano, A. Shekoyan, J. Ahn, C. Moussa (Washington, DC, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Noladin ether attenuates MPTP -induced motor deficit by abrogating pro-inflammatory cytokines and striatal neurochemical alterations in rats

R. Deshmukh, S. Singh (Moga, India)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Non motor symptoms in patients with Writer’s cramp

R. Singh, P. Chatterjee, S. Choudhury, S. Anand, S. Shubham, S. Trivedi, H. Kumar (Kolkata, India)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Non-motor symptom burden is associated with thalamic atrophy in Parkinson’s disease

F. Niccolini, H. Wilson, B. Giordano, K. Diamantopoulos, G. Pagano, K. Ray Chaudhuri, M. Politis (London, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Non-motor symptoms in Parkinson’s disease and putamen dopamine transporter uptake (DaTscan) uptake: a survey of 85 patients

M. Qamar, A. Sauerbier, A. Rizos, K. Chaudhuri (London, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Noninvasive cerebellar stimulation for adults with cervical dystonia

A. McCambridge (Sydney, Australia)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: NS-PARK/FCRIN network, the French Clinical Research Network for Parkinson’s disease and Movement Disorders

E. Dellapina, V. Chaigneau, F. Durif, J.-C. Corvol, O. Rascol, F. NS-PARK/FCRIN network (Toulouse, France)

Other · Exhibit Hall C

1:15pm-2:45pm: NUBPL mutations cause combined dystonia with bilateral striatal necrosis and cerebellar atrophy

B. Balint, G. Charlesworth, M. Stamelou, L. Carr, N. Wood, K. Bhatia (London, United Kingdom)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Observational study of the effectiveness and tolerability of rotigotine+levodopa therapy in older vs younger Parkinson’s disease patients

D. Woitalla, M. Asgharnejad, L. Joeres, J.-C. Schuller, K.R. Chaudhuri (Bochum, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C